Description

4-Piperidinecarboxamide, 1-(6,7-Dihydro-2-Methyl-5H-Cyclopentapyrimidin-4-Yl)-n-(2-Phenylethyl)- (9Ci) is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is of significant value for research and development in medicinal chemistry, particularly in the synthesis of novel therapeutic agents. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new active pharmaceutical ingredients (APIs) and bioactive molecules.

Application

• Pharmaceutical Intermediate: A key building block in the research and synthesis of novel drug candidates targeting central nervous system (CNS) disorders, cardiovascular diseases, or other therapeutic areas.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Chemical Biology Probe: Serves as a precursor for developing molecular probes to study biological pathways and enzyme functions.
• Custom Synthesis: Employed by contract research and manufacturing organizations (CROs/CMOs) for the custom synthesis of complex molecules for clients.
• Reference Standard: Supplied as a high-purity analytical standard for method development and quality control in pharmaceutical analysis.

Basic Information

Product Name	4-Piperidinecarboxamide, 1-(6,7-Dihydro-2-Methyl-5H-Cyclopentapyrimidin-4-Yl)-n-(2-Phenylethyl)- (9Ci)
CAS No.	606135-89-1
Molecular Formula	C21H26N4O
Molecular Weight	350.46 g/mol
Synonyms	1-(6,7-Dihydro-2-methyl-5H-cyclopenta[d]pyrimidin-4-yl)-N-(2-phenylethyl)piperidine-4-carboxamide; 1-(2-Methyl-5,6,7,8-tetrahydrocyclopenta[d]pyrimidin-4-yl)-N-(2-phenylethyl)piperidine-4-carboxamide; 4-Piperidinecarboxamide, 1-(6,7-dihydro-2-methyl-5H-cyclopentapyrimidin-4-yl)-N-(2-phenylethyl)-; N-(2-Phenylethyl)-1-(6,7-dihydro-2-methyl-5H-cyclopenta[d]pyrimidin-4-yl)piperidine-4-carboxamide
EINECS	Contact for details

Quality Control

Our 4-Piperidinecarboxamide, 1-(6,7-Dihydro-2-Methyl-5H-Cyclopentapyrimidin-4-Yl)-n-(2-Phenylethyl)- (9Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing all specifications and test results are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to prevent moisture absorption, which may affect stability and purity. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.